523 related articles for article (PubMed ID: 6150740)
1. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
2. Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors.
Doxey JC; Roach AG; Smith CF
Br J Pharmacol; 1983 Mar; 78(3):489-505. PubMed ID: 6132640
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
Doxey JC; Lane AC; Roach AG; Virdee NK
Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
[TBL] [Abstract][Full Text] [Related]
4. 2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.
Gadie B; Lane AC; McCarthy PS; Tulloch IF; Walter DS
Br J Pharmacol; 1984 Nov; 83(3):707-12. PubMed ID: 6150739
[TBL] [Abstract][Full Text] [Related]
5. Differential blocking actions of idazoxan against the inhibitory effects of 6-fluoronoradrenaline and clonidine in the rat vas deferens.
Hicks PE; Langer SZ; Macrae AD
Br J Pharmacol; 1985 Sep; 86(1):141-50. PubMed ID: 2864967
[TBL] [Abstract][Full Text] [Related]
6. Different sites of action for alpha 2-adrenoceptor antagonists in the modulation of noradrenaline release and contraction response in the vas deferens of the rat.
Harsing LG; Vizi ES
J Pharm Pharmacol; 1992 Mar; 44(3):231-4. PubMed ID: 1354730
[TBL] [Abstract][Full Text] [Related]
7. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
Doxey JC; Roach AG; Samuel J
Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
[TBL] [Abstract][Full Text] [Related]
8. Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.
Hicks PE; Najar M; Vidal M; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):354-61. PubMed ID: 2877400
[TBL] [Abstract][Full Text] [Related]
9. Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the rat.
Berridge TL; Doxey JC; Roach AG; Smith CF
Eur J Pharmacol; 1992 Mar; 213(2):205-12. PubMed ID: 1355733
[TBL] [Abstract][Full Text] [Related]
10. A study of the selectivity and potency of rauwolscine, RX 781094 and RS 21361 as antagonists of alpha-1 and alpha-2 adrenoceptors.
Timmermans PB; Qian JQ; Ruffolo RR; van Zwieten PA
J Pharmacol Exp Ther; 1984 Mar; 228(3):739-48. PubMed ID: 6142941
[TBL] [Abstract][Full Text] [Related]
11. Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.
Bill SJ; Boniface A; Haroun F; McAdams RP; Lattimer N; Rhodes KF
Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):418-22. PubMed ID: 2881217
[TBL] [Abstract][Full Text] [Related]
12. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
[TBL] [Abstract][Full Text] [Related]
13. Alpha-adrenoceptor antagonism by apoyohimbine and some observations on the pharmacology of alpha-adrenoceptors in the rat anococcygeus and vas deferens.
McGrath JC
Br J Pharmacol; 1984 Aug; 82(4):769-81. PubMed ID: 6148114
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological demonstration of both alpha 2-agonist and antagonist properties of RX 781094.
Goldstein JM; Knobloch LC; Malick JB
Eur J Pharmacol; 1983 Jul; 91(1):101-5. PubMed ID: 6137390
[TBL] [Abstract][Full Text] [Related]
15. Studies of alpha 2-adrenoceptor antagonist potency in vitro: comparisons in tissues from rats, rabbits, dogs and humans.
Waterfall JF; Rhodes KF; Lattimer N
Clin Sci (Lond); 1985; 68 Suppl 10():21s-24s. PubMed ID: 2857614
[TBL] [Abstract][Full Text] [Related]
16. Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.
Virtanen R; Savola JM; Saano V
Arch Int Pharmacodyn Ther; 1989; 297():190-204. PubMed ID: 2567152
[TBL] [Abstract][Full Text] [Related]
17. Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro.
Perrone MH; Hamel LT; Ferrari RA; Haubrich DR
J Pharmacol Exp Ther; 1990 Aug; 254(2):471-5. PubMed ID: 1974637
[TBL] [Abstract][Full Text] [Related]
18. Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
Rand MJ; Tung LH; Louis WJ; Story DF
J Mol Cell Cardiol; 1986 Nov; 18 Suppl 5():17-32. PubMed ID: 2433457
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
Medgett IC; Langer SZ
J Pharmacol Exp Ther; 1984 Jun; 229(3):823-30. PubMed ID: 6144792
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.
Lattimer N; McAdams RP; Rhodes KF; Sharma S; Turner SJ; Waterfall JF
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):312-8. PubMed ID: 6151116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
